Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Hydrochloric Acid | HCID 313 | — |
| Reactant | Sodium Hydroxide | HCID 14798 | — |
| Reactant | HCID 57720302 | HCID 57720302 | — |
| Solvent | Tetrahydrofuran | HCID 8028 | — |
| Product | HCID 57720171 | HCID 57720171 | 39.8% |
Reaction Steps
2-(3-Ethoxycarbonylmethyloxy-4-phenylbenzylamino)-1-(β-D-ribofuranosyl)-1H-benzimidazole (53 mg) was dissolved in tetrahydrofuran (5 mL). To the reaction mixture was added 2 mol/L aqueous sodium hydroxide solution (1 mL), and the mixture was stirred 60° C. for 1 hour. To the reaction mixture was added 2 mol/L hydrochloric acid (1 mL), and the solvent was removed under reduced pressure. The obtained residue was purified by preparative reverse phase column chromatography (Shiseido CAPSELL PAC C18UG80, 5 μm, 20×50 mm, flow rate 30 mL/minutes linear gradient, water/methanol=70/30-10/90) to give the title compound (20 mg).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07547680B2 |
|---|
| Source dataset | uspto-grants-2009_06 |
|---|
| ORD ID | ord-6f15c34129724f94980ac75763fa3110 |
|---|
| Source note | uspto-grants-2009_06 |
|---|